Targeting STING pathways for the treatment of cancer

Claudia Gravekamp, Dinesh Chandra

Research output: Contribution to journalArticle

6 Scopus citations

Abstract

Recently, we demonstrated that stimulator of interferon genes (STING) ligand cyclic di-guanylate (c-di-GMP) is an excellent adjuvant in cancer vaccination but also induces immunogenic tumor cell death. Combination of both pathways resulted in a nearly complete elimination of the metastases in a breast cancer model. This study is discussed below.

Original languageEnglish (US)
JournalOncoImmunology
Volume4
Issue number12
DOIs
Publication statusPublished - Dec 2 2015

    Fingerprint

Keywords

  • c-di-GMP
  • IL-12
  • Listeria-Mage-b
  • metastatic breast cancer
  • STING ligand

ASJC Scopus subject areas

  • Immunology and Allergy
  • Oncology
  • Immunology

Cite this